10-K Filing

BNB PLUS CORP. CIK: 744452 FY 2012

Filing Information

Form Type	10-K
Accession Number	`0001188112-12-003634`
Period End Date	20120930
Filing Date	20121220
Fiscal Year	2012
Fiscal Period	FY
XBRL Instance	apdn-20120930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 65 Income Statement 24 Cash Flow Statement 49 Stockholders Equity 27

Balance Sheet 65 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation on property, plant and equipment (in dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$251.96K	USD	Point-in-time
Accumulated depreciation on property, plant and equipment (in dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$210.86K	USD	Point-in-time
Accumulated amortization on capitalized finance costs (in dollars)	`AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts`	$1.89M	USD	Point-in-time
Accumulated amortization on capitalized finance costs (in dollars)	`AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts`	$1.81M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.75M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.62K	USD	Point-in-time
Accumulated amortization on patents (in dollars)	`FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff`	$34.26K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$724.78K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$296.99K	USD	Point-in-time
Accumulated amortization and write off on intellectual property (in dollars)	`FiniteLivedIntellectualPropertyIntangibleAssetsAccumulatedAmortizationAndWriteoff`	$9.43M	USD	Point-in-time
Accumulated amortization and write off on intellectual property (in dollars)	`FiniteLivedIntellectualPropertyIntangibleAssetsAccumulatedAmortizationAndWriteoff`	$9.16M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$208.59K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$76.29K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$80.04K	USD	Point-in-time
Unamortized discount on convertible notes payable, current (in dollars)	`UnamortizedDiscountOnConvertibleNotesPayableCurrent`	$541.12K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.10M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.03M	USD	Point-in-time
Property, plant and equipment-net of accumulated depreciation of $251,958 and $210,862, respectively	`PropertyPlantAndEquipmentNet`	$210.84K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Property, plant and equipment-net of accumulated depreciation of $251,958 and $210,862, respectively	`PropertyPlantAndEquipmentNet`	$89.11K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Deposits	`DepositAssets`	$23.46K	USD	Point-in-time
Deposits	`DepositAssets`	$36.28K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Capitalized finance costs-net of accumulated amortization of $1,892,236 and $1,806,261, respectively	`DeferredFinanceCostsNoncurrentNet`	$85.97K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	800.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.35B	shares	Point-in-time
Patents, net of accumulated amortization of $34,257 (Note B)	`FiniteLivedPatentsIntangibleAssetsNet`	-	USD	Point-in-time
Patents, net of accumulated amortization of $34,257 (Note B)	`FiniteLivedPatentsIntangibleAssetsNet`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	646.18M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	473.33M	shares	Point-in-time
Intellectual property, net of accumulated amortization and write off of $9,430,900 and $9,158,056, respectively (Note B)	`FiniteLivedIntangibleAssetsNet`	$272.84K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	473.33M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	646.18M	shares	Point-in-time
Intellectual property, net of accumulated amortization and write off of $9,430,900 and $9,158,056, respectively (Note B)	`FiniteLivedIntangibleAssetsNet`	-	USD	Point-in-time
Total Assets	`Assets`	$1.35M	USD	Point-in-time
Total Assets	`Assets`	$3.50M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$592.01K	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$768.06K	USD	Point-in-time
Convertible notes payable, net of unamortized discount of $541,120 (Note D)	`ConvertibleNotesPayableCurrent`	$3.73M	USD	Point-in-time
Convertible notes payable, net of unamortized discount of $541,120 (Note D)	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$592.01K	USD	Point-in-time
Commitments and contingencies (Note J)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note J)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2012 and 2011	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2012 and 2011	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 1,350,000,000 and 800,000,000 shares authorized as of September 30, 2012 and 2011, respectively; 646,182,550 and 473,325,859 shares issued and outstanding as of September 30, 2012 and 2011, respectively	`CommonStockValueOutstanding`	$473.33K	USD	Point-in-time
Common stock, par value $0.001 per share; 1,350,000,000 and 800,000,000 shares authorized as of September 30, 2012 and 2011, respectively; 646,182,550 and 473,325,859 shares issued and outstanding as of September 30, 2012 and 2011, respectively	`CommonStockValueOutstanding`	$646.18K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$160.39M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$169.12M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-169.01M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-161.86M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-995.38K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-1.60M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$756.92K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$1.35M	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$3.50M	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
Revenue	`SalesRevenueNet`	$968.85K	USD	Annual
Revenue	`SalesRevenueNet`	$1.85M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$7.62M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$8.39M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$432.67K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$268.88K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$367.56K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$313.94K	USD	Annual
Total operating expenses	`OperatingExpenses`	$9.03M	USD	Annual
Total operating expenses	`OperatingExpenses`	$8.36M	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-8.06M	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-6.51M	USD	Annual
Interest expense, net	`InterestExpense`	$2.46M	USD	Annual
Interest expense, net	`InterestExpense`	$643.06K	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-7.15M	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-10.52M	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	Annual
NET LOSS	`NetIncomeLoss`	$-10.52M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-7.15M	USD	Annual
Net loss per share-basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	Annual
Net loss per share-basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	Annual
Weighted average shares outstanding- basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	376.83M	shares	Annual
Weighted average shares outstanding- basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	576.09M	shares	Annual

Cash Flow Statement 49 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-10.52M	USD	Annual
Net loss	`NetIncomeLoss`	$-7.15M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$367.56K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$313.94K	USD	Annual
Fair value of vested options issued to officers, directors and employees	`AllocatedShareBasedCompensationExpense`	$1.95M	USD	Annual
Fair value of vested options issued to officers, directors and employees	`AllocatedShareBasedCompensationExpense`	$1.49M	USD	Annual
Amortization of capitalized financing costs	`AmortizationOfFinancingCosts`	$85.97K	USD	Annual
Amortization of capitalized financing costs	`AmortizationOfFinancingCosts`	$858.99K	USD	Annual
Amortization of debt discount attributable to convertible debentures	`AmortizationOfDebtDiscountPremium`	$541.12K	USD	Annual
Amortization of debt discount attributable to convertible debentures	`AmortizationOfDebtDiscountPremium`	$331.33K	USD	Point-in-time
Amortization of debt discount attributable to convertible debentures	`AmortizationOfDebtDiscountPremium`	$2.10M	USD	Annual
Equity based compensation	`ShareBasedCompensation`	$58.24K	USD	Annual
Equity based compensation	`ShareBasedCompensation`	$1.44M	USD	Annual
Common stock issued in settlement of interest	`CommonStockIssuedInSettlementOfInterest`	$37.00K	USD	Annual
Common stock issued in settlement of interest	`CommonStockIssuedInSettlementOfInterest`	$102.84K	USD	Annual
Fair value change from employee option modifications	`FairValueOptionChangesInFairValueGainLoss1`	$738.81K	USD	Annual
Increase in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$145.56K	USD	Annual
Increase in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$88.41K	USD	Annual
(Increase) decrease in prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-70.03K	USD	Annual
(Increase) decrease in prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$16.57K	USD	Annual
Increase (decrease) in accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$239.04K	USD	Annual
Increase (decrease) in accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-199.49K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.96M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.76M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$162.83K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$89.11K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-89.11K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-162.83K	USD	Annual
Net proceeds from (payments of) related party advances	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-50.00K	USD	Annual
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$4.74M	USD	Annual
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.10M	USD	Annual
Net proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$1.90M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.10M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$6.58M	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.73M	USD	Annual
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.02M	USD	Annual
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.75M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$17.62K	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$724.78K	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$2.75M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$17.62K	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$724.78K	USD	Point-in-time
Cash paid during period for interest	`InterestPaid`	-	USD	Annual
Cash paid during period for interest	`InterestPaid`	-	USD	Annual
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Fair value of warrants issued for financing costs	`FairValueOfWarrantsIssuedForFinancingCost`	$217.97K	USD	Annual
Common stock issued in exchange for previously incurred debt and related accrued interest	`DebtConversionConvertedInstrumentAmount1`	$373.00K	USD	Annual
Common stock issued in exchange for previously incurred debt and related accrued interest	`DebtConversionConvertedInstrumentAmount1`	$4.69M	USD	Annual

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-995.38K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.60M	USD	Point-in-time
Balance	`StockholdersEquity`	$756.92K	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	473.33M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	646.18M	shares	Point-in-time
Equity based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.95M	USD	Annual
Equity based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$502.80K	USD	Annual
Fair value of vested options issued to directors, officers and employees	`VestedOptionsIssuedToOfficersDirectorsAndEmployees`	$1.49M	USD	Annual
Fair value of vested warrants issued for service	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$217.97K	USD	Annual
Fair value of vested warrants issued for service	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$58.24K	USD	Annual
Common stock issued in settlement of convertible debentures and interest	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$410.00K	USD	Annual
Common stock issued in settlement of convertible debentures and interest	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$4.79M	USD	Annual
Common stock issued in settlement of convertible debentures and interest (in shares)	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	22.92M	shares	Annual
Common stock issued in exchange for consulting services	`StockIssuedDuringPeriodValueIssuedForServices`	$65.00K	USD	Annual
Common stock issued in exchange for consulting services (in shares)	`StockIssuedDuringPeriodSharesIssuedForServices`	888,813.00	shares	Annual
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$2.10M	USD	Annual
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$4.74M	USD	Annual
Common stock issued as officer compensation	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	$877.50K	USD	Annual
Change in fair value of extended vested options	`AdjustmentsToAdditionalPaidInCapitalChangeInFairValueOfExtendedVestedOptions`	$738.81K	USD	Annual
Beneficial conversion feature relating to convertible debentures	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$2.09M	USD	Annual
Net loss	`NetIncomeLoss`	$-10.52M	USD	Annual
Net loss	`NetIncomeLoss`	$-7.15M	USD	Annual
Balance	`StockholdersEquity`	$-995.38K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.60M	USD	Point-in-time
Balance	`StockholdersEquity`	$756.92K	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	473.33M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	646.18M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.